For any questions, concerns, multiple item orders and/or page reproductions, please email libraryservices@freepress.mb.ca.

Close

The Free Press News

RUTH BONNEVILLE / WINNIPEG FREE PRESS

Biz - novel biotech

Photo of Santhosh Kallivalappil, owner of Novel Biotechnology Inc., in his lab Wednesday.  Kallivalappil is working with a Gene synthesizer, a specialized machine to synthesis the human or bacterial gene in lab from nucleotides. This gene can be used for DNA therapy or mRNA vaccines 

Subject: Story about U of M scientist who left Winnipeg to work in the private sector and came back to start his own biotechnology firm – Novel Biotechnology – that has developed a promising technology platform that uses a new kind of bacteria that can produce material much faster for pharmecuetical companies developing vaccines and other therapeutics.

See Cash story.


Jan 17th, 2024

Photo description:

RUTH BONNEVILLE / WINNIPEG FREE PRESS Biz - novel biotech Photo of Santhosh Kallivalappil, owner of Novel Biotechnology Inc., in his lab Wednesday. Kallivalappil is working with a Gene synthesizer, a specialized machine to synthesis the human or bacterial gene in lab from nucleotides. This gene can be used for DNA therapy or mRNA vaccines Subject: Story about U of M scientist who left Winnipeg to work in the private sector and came back to start his own biotechnology firm – Novel Biotechnology – that has developed a promising technology platform that uses a new kind of bacteria that can produce material much faster for pharmecuetical companies developing vaccines and other therapeutics. See Cash story. Jan 17th, 2024

You Might Also Like View More Photos